TraceLink to Present at BIO CEO & Investor Conference
NORTH READING, Mass., Feb. 7, 2018 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Shabbir Dahod, President and CEO, will present at the BIO CEO & Investor Conference on Monday, February 12 at 3:00pm ET at the New York Marriott Marquis in New York, NY. The presentation will take place in the 5th Floor Westside Ballroom.
During his presentation, Dahod will discuss TraceLink's expanding role as a digital health partner for the life sciences industry and its Life Sciences Cloud platform, a transformative information and data-sharing network for companies throughout the pharmaceutical supply chain.
With 265,000 life sciences companies, distributors, hospitals and clinics on its network, TraceLink has built the industry's only end-to-end digital information sharing platform for the pharmaceutical supply chain. TraceLink facilitates the fastest and most comprehensive trade partner and system integrations for serialization, and eliminates the complexities associated with point to point connections.
About TraceLink
TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 177 in 2017), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content:http://www.prnewswire.com/news-releases/tracelink-to-present-at-bio-ceo--investor-conference-300595316.html
SOURCE TraceLink
